MPL anticorps (AA 26-175)
-
- Antigène Voir toutes MPL Anticorps
- MPL (Myeloproliferative Leukemia Virus Oncogene (MPL))
-
Épitope
- AA 26-175
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp MPL est non-conjugé
-
Application
- ELISA, Flow Cytometry (FACS)
- Fonction
- CD110 Antibody
- Purification
- Purified antibody
- Immunogène
- Purified recombinant fragment of human CD110 (AA: 26-175) expressed in E. Coli.
- Clone
- 1D6B7
- Isotype
- IgG2a
- Top Product
- Discover our top product MPL Anticorps primaire
-
-
- Indications d'application
-
ELISA: 1/10000
FCM: 1/200 - 1/400
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Purified antibody in PBS with 0.05 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
- Antigène
- MPL (Myeloproliferative Leukemia Virus Oncogene (MPL))
- Autre désignation
- CD110 (MPL Produits)
- Synonymes
- anticorps C-MPL, anticorps CD110, anticorps MPLV, anticorps THCYT2, anticorps TPOR, anticorps TPO-R, anticorps c-mpl, anticorps c-mpl-I, anticorps c-mpl-II, anticorps hlb219, anticorps MPL, anticorps mpll, anticorps tpor, anticorps tpor.b, anticorps MPL proto-oncogene, thrombopoietin receptor, anticorps myeloproliferative leukemia virus oncogene, anticorps MPL, anticorps Mpl, anticorps mpl
- Sujet
-
Description: In 1990 an oncogene, v-mpl, was identified from the murine myeloproliferative leukemia virus that was capable of immortalizing bone marrow hematopoietic cells from different lineages. In 1992 the human homologue, named, c-mpl, was cloned. Sequence data revealed that c-mpl encoded a protein that was homologous with members of the hematopoietic receptor superfamily. Presence of anti-sense oligodeoxynucleotides of c-mpl inhibited megakaryocyte colony formation. The ligand for c-mpl, thrombopoietin, was cloned in 1994. Thrombopoietin was shown to be the major regulator of megakaryocytopoiesis and platelet formation. The protein encoded by the c-mpl gene, CD110, is a 635 amino acid transmembrane domain, with two extracellular cytokine receptor domains and two intracellular cytokine receptor box motifs . TPO-R deficient mice were severely thrombocytopenic, emphasizing the important role of CD110 and thrombopoietin in megakaryocyte and platelet formation. Upon binding of thrombopoietin CD110 is dimerized and the JAK family of non-receptor tyrosine kinases, as well as the STAT family, the MAPK family, the adaptor protein Shc and the receptors themselves become tyrosine phosphorylated.
Aliases: MPL, MPLV, TPOR, C-MPL, THCYT2
- Poids moléculaire
- 71.2kDa
- ID gène
- 4352
- HGNC
- 4352
- UniProt
- P40238
- Pathways
- Signalistation JAK/STAT
-